Device
[대역어] 장치
[용어속성] Term
[용어속성] Term
Use of Physiological Data From a Wearable Device to Identify SARS-CoV-2 Infection and Symptoms and Predict COVID-19 Diagnosis: Observational Study
웨어러블 기기의 생리학적 데이터를 사용하여 SARS-CoV-2 감염 및 증상 식별 및 COVID-19 진단 예측: 관찰 연구
Original Paper
[키워드] amplitude
app
Apple Watch
autonomic
Autonomic nervous system
Chain Reaction
change
changes in
characterized
collected
COVID-19
COVID-19 diagnosis
COVID-19 infection
COVID-19–related symptoms
data
Device
Diagnosis
diagnosis of COVID-19
downloaded
follow-up period
Health care
heart rate
heart rate variability
HRV
identification
identify
individual
Infection
Infectious disease
Metrics
Mount Sinai
Mount Sinai Health System
nasal swab
nervous system function
objective
Observational
observational study
participant
performed
physiological
polymerase chain
polymerase chain reaction
predict
prediction
Predictive
question
Result
SARS-CoV-2
Significant
significant changes in
Standard deviation
subject
survey
Symptom
Symptoms
System
the mean
uninfected
Variability
Warrior
wearable
wearable device
with infection
[DOI] 10.2196/26107 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/26107 PMC 바로가기 [Article Type] Original Paper
An Autotuning Cable-Driven Device for Home Rehabilitation
Research Article
[키워드] Analysis
analyzed
autonomous
carried
change
COVID-19 pandemic
described
Device
Effects
Evolution
Health Service
home
Injury
limb
Prevent
rehabilitation
[DOI] 10.1155/2021/6680762 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/6680762 PMC 바로가기 [Article Type] Research Article
Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
SARS-CoV-2 항원/항체 검사 등록을 위한 기술검토 요점
Regulatory
[키워드] accelerate
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
antibody
Antigen
approval
caused
center
Clarification
coronavirus
coronavirus disease
coronavirus disease-2019
COVID-19
Device
Evolution
expand
facilitate
initiated
NMPA
outbreak
pandemic
Point
Registration
respiratory
review
SARS-CoV-2
SARS-CoV-2 antigen
Spread
Test
tests
worldwide pandemic
[DOI] 10.4155/bio-2020-0219 PMC 바로가기 [Article Type] Regulatory
[DOI] 10.4155/bio-2020-0219 PMC 바로가기 [Article Type] Regulatory
Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial
글루코코르티코이드(CORTIVID)를 사용한 COVID-19 폐렴의 치료: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] absolute difference
active cancer
Admission
age
allergy
ambient
approved
arterial blood
Barcelona
baseline
biochemical
Blinding
Block randomisation
block size
Blood
Breastfeeding
C-reactive protein
C-reactive protein (CRP
candidate
clinical
Clinical outcome
clinical outcomes
clinical trial
contraindication
Control
control group
Controlled trial
COVID-19
COVID-19 admission
COVID-19 pneumonia
criteria
death
decrease
defined
detect
Deterioration
Device
diabete
Diabetes Mellitus
diagnosis of SARS-CoV-2
discretion
dissemination
drug
drug treatment
early treatment
Effectiveness
element
elevated
eligible
emergency room
ethics committee
EudraCT
exclusion criteria
expected
explained
ferritin
Follow-up
followed by
following
glucocorticoid
Glucocorticoids
groups
hospital
Hospital admission
hypertension
ICU
Identifier
IL-6
immunosuppressants
IMPROVE
inclusion criteria
independent
Infection
inflammatory biomarkers
Informed consent
intensive care
intensive care unit
interleukin
interleukin-6
Intervention
intervention group
intravenous
intravenous infusion
Laboratory
Loading dose
Lopinavir
Lopinavir/ritonavir
maintenance dose
management
manic
manic disorder
mechanical ventilation
Medical devices
Medicine
Medicines
Methylprednisolone
Nasopharyngeal swab
nasopharyngeal swabs
number
objective
outcome
outcome assessor
outcome assessors
Outpatient
oxygen
oxygen saturation
PaO
parallel-group
partial pressure
Partial pressure of oxygen
participant
Patient
patient age
patients
patients with COVID-19
Pharmacy
Placebo
Pneumonia
polymerase chain
Potential
Pregnancy
primary endpoint
Primary outcome
procalcitonin
proportion
protocol
Psychiatric
Psychological
psychotic
pulse
Pulses
Quadruple blind
radiological
random
randomisation
randomised
randomised controlled trial
randomizeR
receive
recommendation
recruit
recruitment
Registered
Remdesivir
required
researcher
reverse transcriptase
Reverse transcriptase polymerase chain reaction
Ritonavir
RT-PCR
Sample size
SARS-CoV-2
SARS-CoV-2 pneumonia
sequence
Spain
Spanish
sputum
Standard of care
status
stratified
study outcomes
Study protocol
supplementary material
Symptom
Tablet
the patient
therapy
title
total sample size
transcriptase
Treatment
treatment failure
Trial
Trial registration
two group
two groups
two-tailed
type I
type II error
uncontrolled hypertension
unit
university
Version
website
with COVID-19
[DOI] 10.1186/s13063-020-04999-4 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04999-4 PMC 바로가기 [Article Type] Letter
Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2
SARS-CoV-2 검출을 위한 WHO 긴급 사용 목록의 신속 항원 검출 키트 평가
Article
[키워드] 2019 novel coronavirus
analytical sensitivity
Antigen
antigen detection
clinical
Clinical characteristics
clinical sensitivity
collected
confirmed COVID-19 patients
COVID-19
COVID-19 patients
determined by
Device
Emergency
evaluate
evaluated
less
limit of detection
list
Novel coronavirus
PanBio
Rapid
Rapid antigen detection
Rapid test
reference method
respiratory
respiratory specimen
respiratory specimens
RT-PCR
SARS-CoV-2
SARS-CoV-2 virus
sensitivity
specimen
Standard Q
Test
the WHO
understanding
was determined
was selected
[DOI] 10.1016/j.jcv.2020.104712 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jcv.2020.104712 PMC 바로가기 [Article Type] Article
China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
Regulatory
[키워드] acute respiratory syndrome
antibody test reagents
approval
caused
center
China
clinical
clinical evaluation
clinician
coronavirus
Coronavirus disease 2019
COVID-19
detection
Device
diagnostic reagent
early stage
emergency approval
Epidemic
gold standard
Infectious disease
NMPA
nucleic acid
pandemic
Perspective
Point
product
reagent
reference method
Registration
released
Requirement
review
SARS-CoV-2
SARS-CoV-2 antibody test
SARS-CoV-2 antibody testing
supplementary detection
[DOI] 10.4155/bio-2020-0188 PMC 바로가기 [Article Type] Regulatory
[DOI] 10.4155/bio-2020-0188 PMC 바로가기 [Article Type] Regulatory
Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial
성인의 중증 COVID-19 치료를 위한 분무형 계면활성제(COV-Surf): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Randomized Controlled Trial
[키워드] 1080
24 hour
24 hours
48 hour
48 hours
ACE2
ADEs
administration
Adverse
adverse event
adverse events
AEs
ALEA
All participant
All participants
allergy
alveolar
angiotensin
angiotensin converting enzyme
angiotensin converting enzyme 2
anticipated
attending physician
bind
Blinding
block randomization
Blood
bovine
breath
buffer
calcium
cells
cellular
cholesterol
Chronic kidney disease
class
clinical
Clinical improvement
clinical trial
clinical trials
Cohort
Combination
comparator
Compliance
Concentration
conducted
Consent
contraindication
contributing to
Control
control arm
controls
COVID-19
COVID-19 adult patient
COVID-19 patients
current
cytokine
Data collection
Data monitoring committee
death
declined
defined
delivery
described
Device
dialysis
discretion
dissemination
dose
drug
Effect
Efficacy
EGFR
element
Eligible participants
end point
End-Expiratory Pressure
Endotracheal intubation
enrolled
Enrollment
enrolment
epithelial
Escalation
EudraCT
evaluate
exclusion
exclusion criteria
expected
fatty
Fatty acid
feasibility
free fatty acid
Frequency
hospital
hospitalised
hypoxia
impair
include
inclusion criteria
index
Inflammatory marker
inflammatory markers
Inflammatory response
intensive care
intensive care unit
Intervention
investigator
Kidney disease
lack
liver
liver failure
Local
lung
lung lavage
mechanical ventilation
mechanical ventilator
mechanically ventilated patient
mechanically ventilated patients
mixture
Mortality
nebulisation
number
objective
Open-label
opinion
Ordinal Scale
other treatment
outcome
oxidative stress
Oxygenation
PaO
participant
Patient
PCR
PEEP
Phosphatidylcholine
phosphatidylethanolamine
phosphatidylglycerol
phosphatidylinositol
phospholipid
PIP
Placebo
plasma
Pneumothorax
Positive end-expiratory pressure
Prevent
Primary outcome
progression
Protein
protocol
pulmonary compliance
pulmonary hemorrhage
pulmonary ventilation
quantification
randomisation
randomised
randomised controlled trial
Randomized
Randomized controlled trial
reached
receive
recorded
recruitment
reduction
Registered
reported
Respiratory failure
SAEs
Sample size
SARS-CoV-2 viral load
SARS-CoV-2 virus
secondary outcome
Secondary outcomes
Serious Adverse Events
severe COVID-19
severity
sphingomyelin
Stage
Standard
Standard of care
status
Study protocol
subject
supplementary material
surface tension
surfactant
synthesis
tension
the WHO
tissue damage
total sample size
tracheal
tracheal aspirate
Tracheal aspirates
transfer
Treatment
Trial
Trial Steering Committee
turnover
unique
university
University College London
usual standard of care
Ventilation
Ventilation Index
ventilatory support
VFD
vibrating mesh nebulizer
Viral
Viral load
virus
water
website
weight
with COVID-19
worsening
[DOI] 10.1186/s13063-020-04944-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
[DOI] 10.1186/s13063-020-04944-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
Disposable silicon-based all-in-one micro-qPCR for apid on-site detection of pathogens
병원체의 신속한 현장 검출을 위한 일회용 실리콘 기반 all-in-one micro-qPCR
Article
[키워드] against SARS-CoV
agent
cDNA
Course
detect
Device
Diagnosis
diagnostic
disease-causing
effective
Electrical and electronic engineering
fragment of
Genomic DNA
infections
Intervention
lab
Laboratory
Mycobacterium
Novel coronavirus
novel coronavirus SARS-CoV-2
nucleic acid
nucleic acids
pathogen
pathogen-specific
Pathogens
produced
Quantitative
Rapid
Real-time PCR
SARS-CoV-2
Sensors and biosensors
Sensors and probes
sequence
silicon
specificity
Symptom
Treatment
[DOI] 10.1038/s41467-020-19911-6 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-020-19911-6 PMC 바로가기 [Article Type] Article
Subject validation of reusable N95 stop-gap filtering facepiece respirators in COVID-19 pandemic
Research Article
[키워드] COVID-19 pandemic
CsA
Department
Device
evaluated
filtration
Final
greater
harmonic mean
healthcare providers
less
median
N95 mask
N95 respirator
N95 respirators
occupational
Particle
Personal protective equipment
positive
public health
Respirator
Result
Safety
scored
significantly higher
tested
threshold
were assessed
widespread
[DOI] 10.1371/journal.pone.0242304 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0242304 PMC 바로가기 [Article Type] Research Article